SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: men mailman who wrote (278)11/29/1997 6:33:00 PM
From: LoLoLoLita  Read Replies (3) of 2068
 
Good News for OXHP longs in Standard & Poors' November 26
issue of The Outlook, pp. 8-9.:

titled "Good Fundamentals with Speculative Kickers:
Attractive Takeover Candidates"

"Our analysts consider the 30 companies ... on the next page
as prime acquisition targets. Even if they're not taken over,
they should do well over the long term."

OXHP is listed there with 4 Stars, Quality Rank B, E1997 earnings
of $0.13, E1998 earnings of $1.70, and the comment "Recent plunge
in stock of HMO makes the company a logical takeover candidate.
OXHP is attractive as the leading HMO in New York."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News